Optimization of MDA With Existing Drug Regimens for LF: Monitoring Efficacy of Ongoing Treatment Programs in PNG

Key facts

Sponsor

University Hospitals Cleveland Medical Center

Principal Investigator

James W Kazura, MD

Case Western Reserve University

Enrollment

3200 enrolled

Eligibility

5 years · All sexes

Timeline

2012 – 2018

Study locations (1)

• Papua New Guinean Institute for Medical Research, Maprik, Sandaun Province, Papua New Guinea

Collaborators

Papua New Guinea Institute of Medical Research

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Filariasis

Additional recruiting or active studies for the same condition.

• RECRUITINGNCT00001230
  Host Response to Infection and Treatment in Filarial Diseases
  National Institute of Allergy and Infectious Diseases (NIAID)

See all trials for Filariasis →